Delays in reporting and publishing trial results during pandemics: cross sectional analysis of 2009 H1N1, 2014 Ebola, and 2016 Zika clinical trials
Abstract Background Pandemic events often trigger a surge of clinical trial activity aimed at rapidly evaluating therapeutic or preventative interventions. Ensuring rapid public access to the complete and unbiased trial record is particularly critical for pandemic research given the urgent associate...
Main Authors: | Christopher W. Jones, Amanda C. Adams, Elizabeth Murphy, Rachel P. King, Benjamin Saracco, Karen R. Stesis, Susan Cavanaugh, Brian W. Roberts, Timothy F. Platts-Mills |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | BMC Medical Research Methodology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12874-021-01324-8 |
Similar Items
-
Comparison of published orthopaedic trauma trials following registration in Clinicaltrials.gov
by: Gandhi Rajiv, et al.
Published: (2011-12-01) -
Impact of a Prescription Support Tool to Improve Adherence to the Guidelines for the Prescription of Oral Antithrombotics: The Combi-AT Randomized Controlled Trial Using Clinical Vignettes
by: Lorène Zerah, et al.
Published: (2019-11-01) -
Problematic trial detection in ClinicalTrials.gov
by: Chris Hartgerink, et al.
Published: (2015-12-01) -
Clinical Trial Registration and Reporting: Drug Therapy and Prevention of Cardiac-Related Infections
by: Lin-Lu Ma, et al.
Published: (2019-07-01) -
Interpretable Trials: Is Interpretability a Reason Why Clinical Trials Fail?
by: Yi-Sheng Chao, et al.
Published: (2021-08-01)